Equities researchers at Seaport Res Ptn lifted their Q1 2025 earnings per share estimates for shares of Avient in a note issued to investors on Tuesday, February 18th. Seaport Res Ptn analyst M.

Seaport Res Ptn upgraded shares of Avient (NYSE:AVNT – Free Report) from a hold rating to a strong-buy rating in a research note published on Tuesday morning,Zacks.com reports. Seaport Res Ptn also ...

Fintel reports that on February 18, 2025, Seaport Global upgraded their outlook for Avient (NYSE:AVNT) from Neutral to Buy.

Seaport Research analyst Michael Harrison upgraded Avient (AVNT) to Buy from Neutral with a $56 price target The company reported another ...

Morgan Stanley analyst Vincent Andrews maintained a Hold rating on Avient (AVNT – Research Report) today and set a price target of $51.00. The ...

Q4 2024 Earnings Call Transcript February 13, 2025 Avient Corporation reports earnings inline with expectations. Reported EPS ...

2025 Full Year Adjusted EPS Guidance: $2.70 to $2.94, with midpoint representing 11% growth excluding FX. Avient Corp ...

Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ETCompany ParticipantsJoe Di Salvo – Vice President-Treasurer ...

Fourth quarter sales increased 4% to $747 million and full year sales increased 3% to $3,240 million Organic sales, which excludes the impact of foreign exchange ...

Avient expects full-year earnings in the range of $2.70 to $2.94 per share. Avient shares have climbed 2% since the beginning of the year. The stock has climbed 11% in the last 12 months.

Bausch & Lomb is now ranked among the top 10 undervalued stocks in the Healthcare sector on the Toronto Stock Exchange. A stock is considered undervalued if it trades at a discount to its ...